价格

MERS-CoV

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Trimeric S1-CD40L fusion protein vaccine against Middle East respiratory syndrome-coronavirus
US 10849972 B2申请人: UNIV KING ABDULAZIZ优先权: 2018
US
8 件公开
MERS-CoV vaccine
- US 10016497 B2
  申请人: UNIV PENNSYLVANIA优先权: 2013
  CN
  US
  6 件公开
- US 2023144060 A1
  申请人: SUMAGEN CANADA INC优先权: 2021
  US
ANTIBODIES
EP 3927432 B1申请人: HARBOUR ANTIBODIES BV优先权: 2019
CN
EP
US
WO
5 件公开
HUMAN ANTIBODIES TO MIDDLE EAST RESPIRATORY SYNDROME -CORONAVIRUS SPIKE PROTEIN
EP 3145539 A1申请人: REGENERON PHARMA优先权: 2014
CN
EP
US
5 件公开
HYBRID INTERFERONS FOR TREATING VIRAL INFECTIONS
EP 4121092 C0申请人: ILC THERAPEUTICS LTD优先权: 2020
CN
EP
US
WO
4 件公开
ALL-IN-ONE AAV VECTORS FOR TREATING CORONAVIRUS-INDUCED DISEASES
EP 4034661 C0申请人: GEORG AUGUST UNIV GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS UNIVSMEDIZIN优先权: 2020
CN
EP
US
WO
4 件公开
PLPRO PROTEIN INHIBITOR, AND PREPARATION METHOD AND APPLICATION THEREOF
US 20250289826 A1申请人: UNIV TSINGHUA优先权: 2022
CN
EP
US
WO
4 件公开
MULTIMERIC CORONAVIRUS BINDING MOLECULES AND USES THEREOF
EP 4188951 A4申请人: IGM BIOSCIENCES INC优先权: 2020
EP
US
WO
4 件公开
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS NEUTRALIZING ANTIBODIES AND METHODS OF USE THEREOF
EP 4112070 A1申请人: DANA FARBER CANCER INST INC优先权: 2014
EP
US
4 件公开
Method for treating respiratory viral infections comprising administration of fatty acid compositions
US 12440464 B2申请人: IRAZU BIO优先权: 2020
US
WO
4 件公开

药物

MERS-CoV

专利

MERS-CoV vaccine